Sign in with Google
bearish
Viva Biotech (维亚生物) IPO: Warning Signs from 2018 Numbers (Part 2)
897 Views28 Mar 2019 07:48
Viva Biotechnology, a China-based drug discovery company, is seeking to raise USD 200m to list on the Hong Kong Stock Exchange. It has recently...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »- Index Treatment of Sony (6758 JP)'s Spinoff of the Financial Services Business
- BYD (1211 HK/002594 CH) - Key Takeaways from AGM
- Xtalpi US$860m IPO Lockup Expiry - Last of the Lockup Release with Nearly All Shares in CCASS Now
- Austal (ASB AU): A Hanwha Bid Is Back In Play
- With Us (9696 JP): NSSK’s JPY3,237 Tender Offer
Top Unpaywalled Insights
More »- Bearishness Persist in Soybeans Despite Rebound Hopes
- Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
- [IO Technicals 2025/23] Bearish Momentum Persists
- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (13 April 2019) - So-Young, Japan Post Trio, Shenwan Hongyuan, Changliao, Uber13 Apr 2019
- ECM Weekly (6 April 2019) - Bilibili, Huya, Qutoutiao, Polycab, PNB Metlife, CIMC Vehicle06 Apr 2019
- ECM Weekly (30 March 2019) - ESR, Yunji, Ruhnn, Jinxin Fertility, Metropolis Health, Viva Biotech30 Mar 2019
- Viva Biotech (维亚生物) IPO: When CRO Becomes Early Stage Biotech Investor03 Jan 2019
- WuXi Apptec (药明康德) IPO: This A+H Listing Will Be Different20 Nov 2018
x